Navigation Links
Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
Date:3/2/2009

BEIJING, March 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Alternext US: SVA), a leading provider of vaccines in China, today announced that it has received the Good Manufacturing Practice (GMP) certification for its recently opened filling and packaging production facility. The certificate of compliance has a five-year term and was issued by the State Food and Drug Administration (SFDA) following a site inspection.

The GMP certification provides for an overall annual production capacity of 20 million doses, with the capability to produce up to 40 million doses through reasonable scheduling of production activities. This production milestone ensures that Sinovac can fully meet increasing market demand and potential production increases for currently commercialized products, namely Healive, Bilive and Anflu. The filling and packaging production plant also has the capabilities to fill and package Panflu, the Company's pandemic influenza vaccine, in order to support China's prevention and control strategy against a potential outbreak of pandemic influenza.

Further to existing commercialized products having obtained GMP certifications, the filling and packaging plant successfully obtained the GMP certification, which further recognizes Sinovac's implementation of high quality management of production process.

Mr. Weidong Yin, Chairman, President and CEO, commented, ''The receipt of the GMP certification and the operation of the state-of-the-art filling and packaging facility provide the foundation for the further development of Sinovac. We are well positioned to increase output to meet increasing market demand and ultimately achieve sales growth. More importantly, the expanded production capacity should enable Sinovac to supply greater amount of vaccines, which is in line with our mission to eliminate human diseases.''

About Sinovac

Sinovac Biotech Ltd. is a Ch
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
2. Sinovac Releases Statement on Healive Vaccine Suspension
3. Sinovac Reports Third Quarter 2008 Unaudited Financial Results
4. Sinovac Named to Deloitte Technology Fast 50 China
5. Sinovac to Participate in Two Upcoming Investor Conferences
6. Sinovacs Credit Rating Upgraded to AAZ, Second Highest Rating
7. Sinovac Biotech Holds 2007 Annual General Meeting
8. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
9. Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
10. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
11. Sinovac Adjourns Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... life sciences product development company that identifies and ... at various stages of development, today provided an ... in the merger of Cytopia Ltd. into YM, ... 2009. The board of directors of Cytopia has ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
(Date:12/10/2009)... Biosciences Corporation (NASDAQ: MATK) announced today that it has ... dairy company Fonterra Co-operative Group Limited for the use of ... products for pregnant and nursing mothers. , ... ... Martek Biosciences Corporation (NASDAQ: MATK) announced today that it ...
(Date:12/10/2009)... -- Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC ... has joined the company,s Board of Directors. Mr. ... School, currently serves on six other corporate boards. ... of four presidential campaigns, including those of John Kerry, ... those roles, he led fundraising of over $800 million. ...
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
... ST. LOUIS, Sept. 12 Prolog Ventures, a ... announced that Dan,Broderick has joined the firm as ... of experience in early-stage investing, venture fund,management, and ... was a managing director at Mason,Wells in Milwaukee, ...
... HOST CONFERENCE CALL AT 10:00AM EDT, EDMONTON, ... BIOM ) (TSX: BRA) (the "Company") today ... a proposal to change its,jurisdiction of incorporation from ... Delaware in the United States of America through ...
... Sept. 12 Genstruct Inc., a,biotechnology company translating ... therapeutics, announced today that its president and,CEO, Dr. ... at the Oncology,Clinical Trial Summit in Arlington, Va., ... a panel discussion focused on,"Enhancing Development and Commercial ...
Other Biology Technology:Dan Broderick Joins Prolog Ventures as Partner 2Dan Broderick Joins Prolog Ventures as Partner 3Biomira Announces Plan to Reincorporate in the United States 2Biomira Announces Plan to Reincorporate in the United States 3Biomira Announces Plan to Reincorporate in the United States 4Biomira Announces Plan to Reincorporate in the United States 5Biomira Announces Plan to Reincorporate in the United States 6Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit 2
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have discovered five genetic variants that are associated with ... an international consortium of 96 scientists from 63 centres ... molecular basis of lung diseases. , The new findings ... Chronic Obstructive Pulmonary Disease (COPD) and asthma. In the ... because the molecular pathways that affect the health of ...
(Date:12/11/2009)... understand that green plants photosynthesize, absorb carbon dioxide ... global-scale effects that photosynthesis has had on Earth. ... origins and evolution of photosynthesis is Jeffrey Touchman, ... Life Sciences. , Oxygen, one of the by-products ... their descendants (including algae and higher plants), transformed ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New genes for lung disease discovered 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Want to attract the opposite sex 3F Its in the Smile 51639 1Want to attract the opposite sex 3F Its in the Smile 51639 2Nick Jonas Opens Up About His Diabetes In Exclusive TV Interview July 19th 2009 on dLife 51637 1Nick Jonas Opens Up About His Diabetes In Exclusive TV Interview July 19th 2009 on dLife 51637 2Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 1Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 2
... Michigan's,Comprehensive Cancer Center and the National Cancer Institute ... of skin cancer.,Andrzej Dlugosz, M.D., a professor of ... the University of Michigan and the National,Cancer Institute ... in basal cell carcinoma ?the most common form ...
... researchers at UT Southwestern Medical Center challenge one of ... one another. , Every time we move, feel emotions, ... our body transmit messages to one another via chemical ... synaptic vesicles that sequester neurotransmitters and release them when ...
... How nature wraps and tags genes determines if and when ... Massachusetts Institute of Technology (M.I.T.). They did the largest, most ... the human genome. , Their findings reveal surprising and previously ... of the human body and in diseases such as cancer. ...
Other Biology News:U-M scientists find genes that control growth of common skin cancer 2U-M scientists find genes that control growth of common skin cancer 3New research questions basic tenet of neuron function 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 3
... Strain Competent Cell Sets Sets of ... combinations The most common method ... coli is to use chemically competent ... in the laboratory, greater efficiency, reproducibility and ...
... The BD Pathway Bioimager is an automated, ... imaging system that has been integrated into ... Pathway was designed to provide high-resolution, automated ... assist in developing better cell-based assays. The ...
... Imager delivers high resolution CCD confocal imaging ... effective optical package that fits on your ... combined with high quantum efficiency CCD cameras, ... recording at up to 100 fps. A ...
... Methylation Kit uses a simplified procedure and ... analysis. The kit is based on the ... cytosine and sodium bisulfite where cytosine is ... Kits innovative in-column desulphonation reaction eliminates several ...
Biology Products: